David S. Goldfarb, MD

About Me

After a difficult personal experience with a kidney stone that required shock wave treatment, I resolved to take care of my fellow patients. I knew the condition was interesting and often neglected, and I felt I needed to do something about it. My background in physiology meant that I was well prepared to study kidney stones.

At NYU Langone, I am committed to patient care and research about kidney stones. I see patients with calcium stones, uric acid stones, struvite stones, cystinuria, and other genetic causes of kidney stones.

I’m also honored to hold several positions of leadership in the field of nephrology. I am the associate editor of the Clinical Journal of the American Society of Nephrology (CJASN), the president of the Research on Calculus Kinetics Society (the R.O.C.K. Society), and the former president of the New York Society of Nephrology. I served as vice chair of the American Urological Association’s guideline panel on the medical management of kidney stones, representing the American Society of Nephrology.

I currently serve on the medical advisory board of the National Kidney Foundation serving Greater New York and the scientific advisory board of the Oxalosis and Hyperoxaluria Foundation.

I am the principal investigator of the Rare Kidney Stone Consortium’s Cystinuria Project, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Advancing Translational Sciences. I’m honored to have been dubbed “Stone Crusher of the Year” by the Oxalosis and Hyperoxaluria Foundation in 2014.


Conditions and Treatments

kidney stones

Credentials

Positions
  • Professor, Department of Medicine
  • Professor, Department of Neuroscience and Physiology
  • Clinical Chief of Nephrology
  • Chief Nephrology at NY Harbor VA Med Ctr
Board Certifications
  • American Board of Internal Medicine (Nephrology), 1988
  • American Board of Internal Medicine - Internal Medicine, 1985
Education and Training
  • Fellowship, NYU Medical Center, Nephrology, 1987
  • Residency, NYU Medical Center, 1985
  • MD from Yale University, 1981

Locations and Appointments

51 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Urology Associates

150 East 32nd Street, 2nd Floor
New York, NY 10016

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

We have established a registry of people with cystinuria. Our goal is to follow people with cystinuria and learn about the course of the disorder. We are also working on developing new drugs for the treatment of cystinuria. The consortium is also learning about Dent disease, primary hyperoxaluria and APRT deficiency (a cause of dihydroxyadenine stones).

Publications

  • The presence of Oxalobacter formigenes in the microbiome of healthy young adults

    Barnett, Clea; Nazzal, Lama; Goldfarb, David S; Blaser, Martin J
    Journal of urology. 2015 Aug. 499-506

  • Institutional characteristics associated with receipt of emergency care for obstructive pyelonephritis at community hospitals

    Borofsky, Michael S; Walter, Dawn; Li, Huilin; Shah, Ojas; Goldfarb, David S; Sosa, R Ernest; Makarov, Danil V
    Journal of urology. 2015 Mar. 193 (3): 851-856

  • The search for monogenic causes of kidney stones [Editorial]

    Goldfarb, David S
    Journal of the American Society of Nephrology. 2015 Mar. 26 (3): 507-510

Read All Publications (171)